Patent · US Active

Cardiac resynchronization using fusion promotion for timing management

US10870008B2 · kind B2 · utility

1Cited by
722References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 23, 2017
Grant dateDec 22, 2020
Priority date
Expiry dateOct 21, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61N1/37512
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

Methods, systems and devices for providing cardiac resynchronization therapy (CRT) to a patient using a leadless cardiac pacemaker and an extracardiac device. The extracardiac device is configured to analyze one or more QRS complexes of the patient's heart, determine whether fusion pacing is taking place, and, if not, to communicate with the leadless cardiac pacemaker to adjust intervals used in the CRT in order to generate desirable fusion of the pace and intrinsic signals. The extracardiac device may take the form of a subcutaneous implantable monitor, a subcutaneous implantable defibrillator, or other devices including wearable devices.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.